Molecular mr imaging of prostate cancer

Avan Kader, Julia Brangsch, Jan O. Kaufmann, Jing Zhao, Dilyana B. Mangarova, Jana Moeckel, Lisa C. Adams, Ingolf Sack, Matthias Taupitz, Bernd Hamm, Marcus R. Makowski

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations


This review summarizes recent developments regarding molecular imaging markers for magnetic resonance imaging (MRI) of prostate cancer (PCa). Currently, the clinical standard includes MR imaging using unspecific gadolinium-based contrast agents. Specific molecular probes for the diagnosis of PCa could improve the molecular characterization of the tumor in a non-invasive examination. Furthermore, molecular probes could enable targeted therapies to suppress tumor growth or reduce the tumor size.

Original languageEnglish
Article number1
Pages (from-to)1-17
Number of pages17
Issue number1
StatePublished - Dec 2021
Externally publishedYes


  • Magnetic resonance imaging
  • Molecular imaging
  • Molecular marker
  • Prostate cancer


Dive into the research topics of 'Molecular mr imaging of prostate cancer'. Together they form a unique fingerprint.

Cite this